SBFM

Sunshine Biopharma Inc.

0.36 USD
-0.03 (-7.37%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sunshine Biopharma Inc. stock is down -55.31% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.67% of the previous 14 June’s closed higher than May.

About Sunshine Biopharma Inc.

Sunshine Biopharma focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement.